Moreover, the expression of insulin promoter factor 1 (PDX1), a master transcriptional regulator of β-cell development and function, is reduced with increased methylation in pancreatic islets of T2D patients, which also corresponds to increased HbA1c levels (Yang et al., 2012). Here, PDX1 is linked to type 2 diabetes mellitus.